As of 2025-07-05, the Intrinsic Value of Precision BioSciences Inc (DTIL) is 5.53 USD. This DTIL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4.34 USD, the upside of Precision BioSciences Inc is 27.5%.
The range of the Intrinsic Value is 5.44 - 5.8 USD.
Based on its market price of 4.34 USD and our intrinsic valuation, Precision BioSciences Inc (DTIL) is undervalued by 27.5%.
Range | Selected | Upside | ||
a | ||||
DCF (Growth Exit 5Y) | 5.44 - 5.8 | 5.53 | 27.5% | |
DCF (Growth Exit 10Y) | 5.26 - 5.27 | 5.26 | 21.3% | |
DCF (EBITDA Exit 5Y) | 5.36 - 5.44 | 5.40 | 24.4% | |
DCF (EBITDA Exit 10Y) | 5.27 - 5.29 | 5.28 | 21.7% | |
Peter Lynch Fair Value | -9.91 - -9.91 | -9.91 | -328.4% | |
P/E Multiples | (17.25) - 0.04 | (12.97) | -398.9% | |
EV/EBITDA Multiples | (12.35) - 9.30 | (4.41) | -201.6% | |
Dividend Discount Model - Multi Stages | 0.01 - 0.03 | 0.02 | -99.6% |
Market Cap (mil) | 48 |
Beta | 0.15 |
Outstanding shares (mil) | 11 |
Enterprise Value (mil) | -7 |
Market risk premium | 5.1% |
Cost of Equity | 9.85% |
Cost of Debt | 7% |
WACC | 8.4% |